Tiziana Life Sciences (NASDAQ: $TLSA) is a biotech firm pushing the boundaries in the discovery and development of novel molecules to treat human diseases. On […]
Category: Red Hot Stocks
Cisco Systems (NASDAQ: CSCO) Releases Q2 Fiscal 2025 Results: Is Cisco A Buy Amid AI Push?
Cisco Systems (NASDAQ: $CSCO) released its Q2 fiscal 2025 results on Wednesday, February 12, 2025, after markets closed, to a positive market reaction. The giant […]
Gilead Sciences (NASDAQ: GILD) Releases Q4 Fiscal 2024 Earnings: Is The Biotech Giant Still A Great Investment In 2025?
Gilead Sciences (NASDAQ: $GILD) is a biotech giant that develops and sells drugs and invests in public health programs. On Tuesday, February 12, 2025, after […]
Coca-Cola (NYSE: KO) Releases Q4 Fiscal 2024 Results: Is This Dividend Aristocrat Still A Buy in 2025?
Coca-Cola (NYSE: KO) is a global beverage company known for its soft drinks, bottled water, coffee, and tea. Following the earnings and revenue beat in […]
McDonald’s (NYSE: MCD) Releases Q4 2024 Earnings: Is McDonald’s Still A Buy in 2025?
McDonald’s (NYSE: $MCD), the global fast food restaurant chain that sells burgers, fries, and more, released its Q4 fiscal 2024 earnings results on Monday, February […]
Amazon (NASDAQ: AMZN) Releases Q4 Fiscal 2024 Earnings: IS AMZN Stock Still A Buy?
Amazon (NASDAQ: AMZN) released mixed q4 fiscal 2024 earnings results to a mixed market reaction on Thursday, February 6, 2025, after markets closed. While revenue […]